2012
DOI: 10.1177/039463201202500229 View full text |Buy / Rent full text
|
|

Abstract: Pegylated-interferon (peg-IFN) and ribavirin combination therapy for the treatment of hepatitis C virus (HCV) infection is well known to be associated with significant adverse effects. Several studies have investigated a possible auditory pathway involvement during IFN therapy, but a method to monitor the potential auditory involvement during treatment has not yet been described. The aim of this study is to evaluate possible modifications of the outer hair cell (OHC) function in HCV patients receiving peg-IFN … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals